Evaluating β-amyloidosis progression in Alzheimer’s disease with Mueller polarimetry
Borovkova, Mariia; Bykov, Alexander; Popov, Alexey; Pierangelo, Angelo; Novikova, Tatiana; Pahnke, Jens; Meglinski, Igor (2020-07-21)
M. Borovkova, A. Bykov, A. Popov, A. Pierangelo, T. Novikova, J. Pahnke, and I. Meglinski, "Evaluating β-amyloidosis progression in Alzheimer’s disease with Mueller polarimetry," Biomed. Opt. Express 11, 4509-4519 (2020). https://doi.org/10.1364/BOE.396294
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement. Users may use, reuse, and build upon the article, or use the article for text or data mining, so long as such uses are for non-commercial purposes and appropriate attribution is maintained. All other rights are reserved.
https://rightsstatements.org/vocab/InC/1.0/
https://urn.fi/URN:NBN:fi-fe2020081148295
Tiivistelmä
Abstract
We applied the wide-field Mueller imaging polarimetry for the screening of formalin-fixed paraffin-embedded samples of mouse brain tissue at different stages of brain β-amyloidosis in Alzheimer’s disease (AD). The accumulation of amyloid-beta (Aβ) deposits throughout the brain tissue is one of the key pathological hallmarks observed with the AD progression. We demonstrate that the presence of Aβ plaques influences the properties of backscattered polarized light, in particular, its degree of depolarization. By means of statistical analysis, we demonstrate that the high-order statistical moments of depolarization distributions, acquired with the multi-spectral Mueller imaging polarimetry, can be used as sensitive markers of the growing presence of Aβ plaques. The introduced label-free polarimetric approach has a potential to facilitate the current practice of the histopathology screening in terms of diagnosis accuracy, time and cost efficiency.
Kokoelmat
- Avoin saatavuus [41752]